We encourage authors to provide detailed information within their submission to facilitate the interpretation and replication of experiments. Authors can upload supporting documentation to indicate the use of appropriate reporting guidelines for health-related
Sample-size estimation
• You should state whether an appropriate sample size was computed when the study was being designed • You should state the statistical method of sample size computation and any required assumptions • If no explicit power analysis was used, you should describe how you decided what sample (replicate) size (number) to use Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
Replicates
• You should report how often each experiment was performed • You should include a definition of biological versus technical replication • The data obtained should be provided and sufficient information should be provided to indicate the number of independent biological and/or technical replicates • If you encountered any outliers, you should describe how these were handled • Criteria for exclusion/inclusion of data should be clearly stated • High-throughput sequence data should be uploaded before submission, with a private link for reviewers provided (these are available from both GEO and ArrayExpress)
Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
Due to the nature of the experiments performed, no patients or animals were employed and thus, no sample size calculations were performed for the present work. Standard GLPs guidelines were followed in order to design our experiments. confidence intervals. These should be reported for all key questions and not only when the p-value is less than 0.05.
(For large datasets, or papers with a very large number of statistical tests, you may upload a single table file with tests, Ns, etc., with reference to sections in the manuscript.)
Biochemical data were obtained from three replicate experiments carried out in three different days using at least two samples for each condition. We made no allusion to this experimental design as they are indicated in standard GLPs.
Due to the nature of X-ray crystallography experiments, no biological replication is applicable. Structure determination was performed from a single crystal of each condition (BeF 3 or AlF 3 -)
Fiber diffraction experiments were performed as mentioned in materials and methods. Each sample was used to obtain between 4 and 6 images and each dataset contains at least 24 independent images.
Any further information can be reported or included in the manuscript upon request.
All biochemical data are presented in Figure 2 as Average ± Standard error.
X-ray crystallography experiments and final image statistics were calculated using the programs indicated in material and methods section. Indexed and integrated images were scaled using AIMLESS software in which completeness, redundancy, coherence (CC 1/2), single reflection significance (I/σI), data quality (R merge , R p.i.m. ) and model quality indicators (R work /R free ) are detailed in Table 1 .
Fiber diffraction data detailed in Table 3 are presented as Average ± Standard error. Lateral metric error calculations were performed from J 0 and J n intensity maxima standard deviations. Longitudinal metric errors were calculated from fitting goodness to Lorentzian normal distribution function, as detailed in Material and Methods section.
